Gentris Corporation Announces Pharmacogenomics Collaboration With MDS Pharma Services

November 27, 2001 - Gentris Corporation, a clinical pharmacogenomics testing and diagnostic products company, has signed a collaboration agreement with MDS Pharma Services, a contract research organization, based in Montreal, Quebec, to establish a confidential database of genotyped volunteers and a repository for commercial development of diagnostic reference controls.

MDS Pharma Services Applies Leading-Edge Technology to Assess Cardiac Electrophysiological Safety of Drugs

November 15, 2001 - MDS Pharma Services announced that it is now offering the HERG K+ Channel Patch-Clamp Assay, which is GLP-compliant and expanding its breadth of pharmacology assays, already the broadest in the industry.

MDS Pharma Services Announces Addition of BIACORE 3000 System

October 16, 2001 - MDS Pharma Services announced today that it has purchased the BIACORE 3000 instrumentation system for use in bioanalytical research, including drug discovery assignments.

MDS Pharma Services Promotes Bill Tracewell, Ph.D., to Associate Director, PK/PD, Lincoln

October 4, 2001 - MDS Pharma Services is pleased to announce the promotion of Bill Tracewell, Ph.D., to the position of associate director, pharmacokinetics/pharmacodynamics (PK/PD).

MDS Pharma Services Appoints Marika DiMarco, Ph.D., to Associate Director, Pharmacokinetics

September 25, 2001 - MDS Pharma Services is pleased to announce the appointment of Marika DiMarco, PhD, to the position of associate director, pharmacokinetics.

MDS Pharma Services Names John Friesner Vice President, Business Development, Discovery and Preclinical

September 12, 2001 - MDS Pharma Services is pleased to announce the addition of John Friesner as vice president, business development, for its discovery and preclinical business unit.

MDS Pharma Services Continues to Add Industry Expertise to its Pharmacology Consulting Group

September 7, 2001 - MDS Pharma Services is pleased to announce the addition of Dr. Daniel Menard, a specialist in functional pharmacology, to its prestigious pharmacology consulting group.

MDS Pharma Services Announces the Addition of a New Industry Expert to its Pharmacology Consulting Group

September 6, 2001 - MDS Pharma Services is pleased to announce the appointment of Dr. Peter Chiu to its pharmacology consulting group.

MDS Pharma Services Enhances Scientific Capabilities with API 4000 LC/MS/MS System

August 16, 2001 - MDS Pharma Services has become the first contract research organization to purchase the API 4000 LC/MS/MS System from Applied Biosystems/MDS Sciex.

MDS Pharma Services names Dr. Qing-An Jiao to be Site Manager in Beijing

August 7, 2001 - MDS Pharma Services is pleased to announce the addition of Dr. Qing-An Jiao to the staff at its China facility in Beijing. Dr. Jiao will serve as site manager.

MDS Pharma Services Names Tim Shull to Business Development Team

July 27, 2001 - MDS Pharma Services is pleased to announce the addition of Tim Shull as business development representative covering the southwest United States.

MDS Pharma Services Names Lorella Di Donato, Ph.D., Director of the Ligand Binding Department at St. Laurent

July 19, 2001 - MDS Pharma Services is pleased to announce that Lorella Di Donato, Ph.D., is now the senior director of the ligand services group at its St. Laurent site.

MDS Pharma Services Announces the Addition of Three Business Development Directors

July 17, 2001 - MDS Pharma Services is pleased to announce the addition of three business development directors to its international staff. Victoria Wray has been named business development director for bioanalytical.

MDS Pharma Services Announces Additions to European Staff

July 17, 2001 - MDS Pharma Services is pleased to announce the following additions to its European clinical research staff: Dr. Jean-Michel Andrieux as director of quality assurance, Europe, and Christian Buhlmann as director of business development, Germany.

MDS Pharma Services Names Dominique Gerbet Director, Business Development at Paris, France Facility

July 5, 2001 - MDS Pharma Services is pleased to announce that Dominique Gerbet, is now the director of the business development at its Paris, France clinical research site.

MDS Pharma Services Announces New Brussels Location

June 13, 2001 - MDS Pharma Services, one of the leading contract research organizations in the world, recently opened a new location in Brussels, Belgium, to oversee activities in Belgium and Holland.

MDS Pharma Services Announces Appointments to Leadership Team

May 30, 2001 - MDS Pharma Services today announced key appointments to its leadership team, in response to the tremendous growth and opportunity facing the organization.

MDS Pharma Services Names Werner Weber, M.D., as Director of Operations, Early Clinical Research, Hamburg

May 7, 2001 - MDS Pharma Services, one of the leading contract research organizations in the world, is pleased to announce the addition of Dr. Werner Weber to its staff as managing director, early clinical research, Hamburg, Germany.

MDS Pharma Services Adopts EP Series' From InnaPhase to Speed Early Drug Development Services

April 18, 2001 - InnaPhase Corporation, the first and only provider of end-to-end software solutions for early drug development teams, announced today that MDS Pharma Services, one of the leading contract research organizations (CRO) in the world, has signed a global license agreement to implement InnaPhase's Enterprise Pharmacology Series (EP2).

MDS Pharma Services Targets Proteomics Research with Purchase of Applied Biosystems//MDS SCIEX API QSTAR™ PulsarHybrid LC/MS/MS System

March 29, 2001 - MDS Pharma Services, a global leader in bioanalytical services, continues to advance in the application of mass spectrometry techniques in drug development with the purchase of the Applied Biosystems/ MDS SCIEX API QSTAR™ Pulsar Hybrid LC/MS/MS System, a quadrupole time-of-flight mass spectrometer.

MDS Pharma Services Achieves Quality Management System Registration to ISO 9001 at Tampa Facility

March 28, 2001 - MDS Pharma Services is pleased to announce that its Pharmaceutics facility in Tampa, Fla., has been registered as compliant with the international quality standard ISO 9001.

MDS Pharma Services Announces Recent Appointments in Business Development, Global Clinical Research

March 22, 2001 - MDS Pharma Services, one of the leading contract research organizations (CRO) in the world, is pleased to announce recent appointments in clinical research, an area in which the company has more than 20 years of experience, global reach, and unmatched expertise.

MDS Pharma Services Promotes Terry Lenehan, Ph.D., to Vice President, Clinical Operations, Europe

March 12, 2001 - MDS Pharma Services is pleased to announce the promotion of Terry J. Lenehan, Ph.D., to the position of vice president, clinical operations, Europe.

MDS Pharma Services appoints Dr. Bernard Gibbs as Research Fellow, Applied Research & Development Group

March 7, 2001 - MDS Pharma Services is pleased to announce the appointment of Dr. Bernard Gibbs as Research Fellow in its bioanalytical applied research and development group.

MDS Pharma Services First Annual Applied Research & Development Symposium Brings Together Leading Scientists

February 27, 2001 - MDS Pharma Services, the third largest contract research organization (CRO) in the world, recently held its first applied research and development (ARD) group symposium.

MDS Pharma Services and InnaPhase Collaborate to Enhance Early Drug Development Worldwide

February 20, 2001 - InnaPhase Corporation, the first and only provider of end-to-end software solutions for early drug development teams, and MDS Pharma Services, the third largest contract research organization (CRO) in the world, have signed a global license agreement to implement InnaPhase's Watson™ Laboratory Information Management System (LIMS).

MDS Pharma Services adds John H. Dillon II as Senior Vice President

February 8, 2001 - MDS Pharma Services is pleased to announce the addition of John Dillon II to its executive team. Dillon will serve as a senior vice president and operate from the organization's office in Philadelphia, Pa.